Status | Study |
Recruiting |
Study Name: Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions Condition: Pheochromocytoma Paraganglioma Inher Date: 2017-05-05 Interventions: Genetic: Genetic screening Germline and/or tumor samples will be screened for mutations |
Completed |
Study Name: Prospective Study of 2 mm Margins for the Biopsy of Dysplastic Nevi Condition: Dysplastic Nevi Date: 2017-03-23 Interventions: Procedure: Saucerization biopsy 2 mm saucerization biopsy of dysplastic nevi |
Recruiting |
Study Name: Impact of a Process Intervention on Screening and Testing Outcomes for Common Hereditary Cancer Syndromes Condition: Hereditary Cancer Date: 2017-03-01 Interventions: Diagnostic Test: Diagnostic Test Genetic Diagnostic Testing |
Recruiting |
Study Name: Familial Investigations of Childhood Cancer Predisposition Condition: Acute Leukemia Adenomatous Polyposis Adrenocortical Carcin Date: 2017-02-08 |
Recruiting |
Study Name: Hereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition to Gastric Cancer Condition: Stomach Neoplasms Stomach Cancer Familial Cancer Date: 2017-01-24 |
Recruiting |
Study Name: Assessment of Safety of Air Travel in Patients With Birt-Hogg-Dube Syndrome Condition: Birt-Hogg-Dube Syndrome Date: 2017-01-05 Interventions: Other: Non-Interventional Study |
Recruiting |
Study Name: Pilot Study of Nivolumab in Pediatric Patients With Hypermutant Cancers Condition: Refractory or Recurrent Hypermutated Malignancies Biallelic Mismatch Repair Deficiency (bMMR Date: 2016-12-02 Interventions: Drug: Nivolumab Nivolumab (also referred to as BMS-936558 or MDX1106) is a human monoclonal antibody (Hu |
Recruiting |
Study Name: RAD001 and Neurocognition in PTEN Hamartoma Tumor Syndrome (PTEN) Condition: PTEN Gene Mutation PTEN Hamartoma Tumor Syndrome Date: 2016-12-02 Interventions: Drug: RAD001 |
Recruiting |
Study Name: Prevalence of Spontaneous Pneumothorax in BHD Condition: Spontaneous Pneumothorax Date: 2016-01-23 Interventions: Radiation: CT scan of the thorax |
Recruiting |
Study Name: Everolimus Therapy in People With Birt-Hogg-Dube Syndrome (BHD)-Associated Kidney Cancer or Sporadic Chromophobe Renal Cancer Condition: Renal Cancer Chromophobe Renal Cell Carcinoma Birt-Hogg-Du Date: 2015-07-21 Interventions: Drug: Everolimus Everolimus is a commercial agent and is supplied by Novartis. |